BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1535 related articles for article (PubMed ID: 31596707)

  • 41. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Pineda AM; Kevin Harrison J; Kleiman NS; Reardon MJ; Conte JV; O'Hair DP; Chetcuti SJ; Huang J; Yakubov SJ; Popma JJ; Beohar N
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):740-748. PubMed ID: 30341970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An updated meta-analysis of TAVR in patients at intermediate risk for SAVR.
    Lazkani M; Singh N; Howe C; Patel N; Colón MJ; Tasset M; Amabile O; Morris M; Fang HK; Pershad A
    Cardiovasc Revasc Med; 2019 Jan; 20(1):57-69. PubMed ID: 29748086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcatheter vs surgical aortic valve replacement in patients with interstitial lung disease.
    Hirji SA; Cote C; Lee J; Kiehm S; McGurk S; Pelletier MP; Aranki S; Shekar P; Shah P; Kaneko T
    J Card Surg; 2020 Mar; 35(3):571-579. PubMed ID: 31981435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Condado JF; Maini A; Leshnower B; Thourani V; Forcillo J; Devireddy C; Mavromatis K; Sarin EL; Stewart J; Guyton R; Simone A; Keegan P; Lerakis S; Block PC; Babaliaros V
    Catheter Cardiovasc Interv; 2017 May; 89(6):1109-1115. PubMed ID: 28211605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-Analysis Comparing Results of Transcatheter Versus Surgical Aortic-Valve Replacement in Patients With Severe Aortic Stenosis.
    Zhang X; Wang T; Lan R; Dai Q; Kang L; Wang L; Wang Y; Xu W; Xu B
    Am J Cardiol; 2020 Feb; 125(3):449-458. PubMed ID: 31780077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular Outcomes with Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials.
    Kundu A; Sardar P; Malhotra R; Qureshi WT; Kakouros N
    Cardiovasc Revasc Med; 2020 Apr; 21(4):453-460. PubMed ID: 31669113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
    Bendayan M; Messas N; Perrault LP; Asgar AW; Lauck S; Kim DH; Arora RC; Langlois Y; Piazza N; Martucci G; Lefèvre T; Noiseux N; Lamy A; Peterson MD; Labinaz M; Popma JJ; Webb JG; Afilalo J
    JACC Cardiovasc Interv; 2020 May; 13(9):1058-1068. PubMed ID: 32381184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
    Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.
    Werner N; Zahn R; Beckmann A; Bauer T; Bleiziffer S; Hamm CW; Berkeredjian R; Berkowitsch A; Mohr FW; Landwehr S; Katus HA; Harringer W; Ensminger S; Frerker C; Möllmann H; Walther T; Schneider S; Lange R;
    Circulation; 2018 Dec; 138(23):2611-2623. PubMed ID: 30571255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of periprocedural and mid-term stroke rates and outcomes between surgical aortic valve replacement and transcatheter aortic valve replacement patients.
    Aalaei-Andabili SH; Anderson RD; Petersen JW; Beaver TM; Bavry AA; Klodell CT
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):591-597. PubMed ID: 27078127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Stroke Volume Index and Left Ventricular Ejection Fraction on Mortality After Aortic Valve Replacement.
    Ito S; Nkomo VT; Orsinelli DA; Lin G; Cavalcante J; Popma JJ; Adams DH; Checuti SJ; Deeb GM; Boulware M; Huang J; Little SH; Cohen SA; Reardon MJ; Oh JK
    Mayo Clin Proc; 2020 Jan; 95(1):69-76. PubMed ID: 31902431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.
    Durko AP; Reardon MJ; Kleiman NS; Popma JJ; Van Mieghem NM; Gleason TG; Bajwa T; O'Hair D; Brown DL; Ryan WH; Chang Y; De Leon SD; Kappetein AP
    J Am Coll Cardiol; 2018 Oct; 72(18):2109-2119. PubMed ID: 30360820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
    Skelding KA; Yakubov SJ; Kleiman NS; Reardon MJ; Adams DH; Huang J; Forrest JK; Popma JJ
    Am J Cardiol; 2016 Aug; 118(4):560-6. PubMed ID: 27381665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
    Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
    JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Dhoble A; Bhise V; Nevah MI; Balan P; Nguyen TC; Estrera AL; Smalling RW
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):90-96. PubMed ID: 28846185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute kidney injury after aortic valve replacement in a nationally representative cohort in the USA.
    Kumar N; Garg N
    Nephrol Dial Transplant; 2019 Feb; 34(2):295-300. PubMed ID: 29684164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial.
    Thyregod HG; Steinbrüchel DA; Ihlemann N; Ngo TA; Nissen H; Kjeldsen BJ; Chang Y; Hansen PB; Olsen PS; Søndergaard L
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):721-728. PubMed ID: 27005980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.